| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 6 |
| GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: Q4QI07
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.434 |
| CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.482 |
| CLV_PCSK_FUR_1 | 33 | 37 | PF00082 | 0.447 |
| CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.436 |
| DEG_SPOP_SBC_1 | 91 | 95 | PF00917 | 0.461 |
| DOC_MAPK_gen_1 | 25 | 34 | PF00069 | 0.642 |
| DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.520 |
| DOC_WW_Pin1_4 | 102 | 107 | PF00397 | 0.545 |
| DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.604 |
| DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.657 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.655 |
| LIG_BRCT_BRCA1_1 | 1 | 5 | PF00533 | 0.650 |
| LIG_FHA_1 | 12 | 18 | PF00498 | 0.680 |
| LIG_FHA_2 | 93 | 99 | PF00498 | 0.563 |
| LIG_LIR_Nem_3 | 60 | 66 | PF02991 | 0.432 |
| LIG_LIR_Nem_3 | 76 | 82 | PF02991 | 0.538 |
| LIG_NRBOX | 16 | 22 | PF00104 | 0.617 |
| LIG_PDZ_Class_3 | 115 | 120 | PF00595 | 0.425 |
| LIG_PTB_Apo_2 | 53 | 60 | PF02174 | 0.442 |
| LIG_PTB_Phospho_1 | 53 | 59 | PF10480 | 0.445 |
| LIG_SH2_CRK | 63 | 67 | PF00017 | 0.411 |
| LIG_SH2_STAP1 | 59 | 63 | PF00017 | 0.381 |
| LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.664 |
| LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.427 |
| LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.175 |
| LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.370 |
| LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.504 |
| LIG_SH3_3 | 100 | 106 | PF00018 | 0.469 |
| LIG_SH3_3 | 23 | 29 | PF00018 | 0.610 |
| LIG_SxIP_EBH_1 | 84 | 96 | PF03271 | 0.499 |
| LIG_TRFH_1 | 19 | 23 | PF08558 | 0.670 |
| MOD_CDC14_SPxK_1 | 22 | 25 | PF00782 | 0.610 |
| MOD_CDK_SPxK_1 | 19 | 25 | PF00069 | 0.614 |
| MOD_CK1_1 | 105 | 111 | PF00069 | 0.611 |
| MOD_CK1_1 | 92 | 98 | PF00069 | 0.514 |
| MOD_CK2_1 | 25 | 31 | PF00069 | 0.573 |
| MOD_CK2_1 | 92 | 98 | PF00069 | 0.558 |
| MOD_Cter_Amidation | 6 | 9 | PF01082 | 0.489 |
| MOD_DYRK1A_RPxSP_1 | 25 | 29 | PF00069 | 0.649 |
| MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.786 |
| MOD_GSK3_1 | 104 | 111 | PF00069 | 0.607 |
| MOD_GSK3_1 | 21 | 28 | PF00069 | 0.677 |
| MOD_GSK3_1 | 57 | 64 | PF00069 | 0.376 |
| MOD_GSK3_1 | 85 | 92 | PF00069 | 0.524 |
| MOD_NEK2_1 | 109 | 114 | PF00069 | 0.526 |
| MOD_PKA_2 | 12 | 18 | PF00069 | 0.628 |
| MOD_Plk_1 | 57 | 63 | PF00069 | 0.378 |
| MOD_Plk_4 | 74 | 80 | PF00069 | 0.498 |
| MOD_ProDKin_1 | 102 | 108 | PF00069 | 0.544 |
| MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.599 |
| TRG_ENDOCYTIC_2 | 63 | 66 | PF00928 | 0.409 |
| TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.522 |
| TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.630 |
| TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.513 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5B9 | Leptomonas seymouri | 59% | 100% |
| A0A0S4JU07 | Bodo saltans | 31% | 100% |
| A0A3S7WQJ7 | Leishmania donovani | 88% | 100% |
| A4H5J4 | Leishmania braziliensis | 71% | 99% |
| A4HTT7 | Leishmania infantum | 88% | 100% |
| D0A994 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
| E9AML8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 95% |
| V5BIJ0 | Trypanosoma cruzi | 49% | 100% |